A major challenge in ethanol research is to identify the molecular events that underlie ethanol abuse and its chronic neurologic sequelae, and to use this information to design strategies for preventing or reversing these conditions. Voltage-dependent Ca2+ channels have a fundamental role in regulating neuronal function and alterations in Ca2+ flux may be prominently involved in ethanol's effects on the nervous system. In preliminary studies, we have investigated acute and long-term modulation of Ca2+ channel function by ethanol using PC12, a clonal cell line of neural crest origin, as a model neural system. Acute exposure to ethanol inhibited K+-depolarization-evoked 45Ca2+ uptake into PC12 cells, while prolonged (2-10 days) exposure led to a reciprocal increase in 45Ca2+ uptake and in the number of Ca2+ channel binding sites labeled by the Ca2+ channel antagonist, (3H)nitrendipine. When ethanol was withdrawn from cultures, 45Ca2+ uptake returned to pre-exposure levels. These findings suggest that neuronal adaptation to ethanol may involve enhanced expression of voltage-dependent Ca2+ channels.
The specific aims of the proposed research are to investigate possible mechanisms for the acute inhibition of 45Ca2+ uptake by ethanol; examine the relationship between acute inhibition of Ca2+ flux and long-term enhancement of 45Ca2+ uptake and 3H- Ca2+ channel antagonist binding; determine whether the acute and long-term effects of ethanol are reproduced by other sedative drugs such as barbiturates and benzodiazepines; explore the possibility of modifying the long-term response to ethanol using Ca2+ channel agonist drugs; and compare the acute and long-term effects of ethanol on Ca2+ channels in undifferentiated PC12 cells, PC12 cells differentiated by treatment with nerve growth factor, and cerebral cortical neurons in primary culture. The methods to be used in these studies include PC12 cell culture, primary culture of cerebral cortical neurons, 45Ca2+ uptake assays, and 3H- Ca2+ channel antagonist binding to intact cells.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA007032-07
Application #
3110553
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1989-07-01
Project End
1993-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ahern, K B; Lustig, H S; Greenberg, D A (1994) Enhancement of NMDA toxicity and calcium responses by chronic exposure of cultured cortical neurons to ethanol. Neurosci Lett 165:211-4
Koretz, B; von B Ahern, K; Wang, N et al. (1994) Pre- and post-synaptic modulators of excitatory neurotransmission: comparative effects on hypoxia/hypoglycemia in cortical cultures. Brain Res 643:334-7
Greenberg, D A (1993) Ethanol and sedatives. Neurol Clin 11:523-34
Ahern, K V; Lustig, H S; Chan, J et al. (1993) Calcium indicators and excitotoxicity in cultured cortical neurons. Neurosci Lett 162:169-72
Lustig, H S; Chan, J; Greenberg, D A (1992) Comparative neurotoxic potential of glutamate, endothelins, and platelet-activating factor in cerebral cortical cultures. Neurosci Lett 139:15-8
Lustig, H S; von Brauchitsch, K L; Chan, J et al. (1992) Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures. Brain Res 577:343-6
Lustig, H S; Chan, J; Greenberg, D A (1992) Ethanol inhibits excitotoxicity in cerebral cortical cultures. Neurosci Lett 135:259-61
Lustig, H S; von Brauchitsch, K L; Chan, J et al. (1992) A novel inhibitor of glutamate release reduces excitotoxic injury in vitro. Neurosci Lett 143:229-32
Lustig, H S; von Brauchitsch, K L; Chan, J et al. (1992) Ethanol and excitotoxicity in cultured cortical neurons: differential sensitivity of N-methyl-D-aspartate and sodium nitroprusside toxicity. J Neurochem 59:2193-200
Lustig, H S; Ahern, K V; Greenberg, D A (1992) Antiparkinsonian drugs and in vitro excitotoxicity. Brain Res 597:148-50

Showing the most recent 10 out of 26 publications